Published in Microb Cell Fact on November 24, 2010
Zymomonas mobilis: a novel platform for future biorefineries. Biotechnol Biofuels (2014) 0.98
Engineering Escherichia coli for succinate production from hemicellulose via consolidated bioprocessing. Microb Cell Fact (2012) 0.95
Systems biology analysis of Zymomonas mobilis ZM4 ethanol stress responses. PLoS One (2013) 0.94
Significance of CO2 donor on the production of succinic acid by Actinobacillus succinogenes ATCC 55618. Microb Cell Fact (2011) 0.90
Applications of genome-scale metabolic network model in metabolic engineering. J Ind Microbiol Biotechnol (2014) 0.89
Succinate production in Escherichia coli. Biotechnol J (2011) 0.87
Elucidation of Zymomonas mobilis physiology and stress responses by quantitative proteomics and transcriptomics. Front Microbiol (2014) 0.84
N2 gas is an effective fertilizer for bioethanol production by Zymomonas mobilis. Proc Natl Acad Sci U S A (2015) 0.83
Zymomonas mobilis as a model system for production of biofuels and biochemicals. Microb Biotechnol (2016) 0.81
Insights into acetate toxicity in Zymomonas mobilis 8b using different substrates. Biotechnol Biofuels (2014) 0.81
Flux-sum analysis identifies metabolite targets for strain improvement. BMC Syst Biol (2015) 0.77
Metabolic network model guided engineering ethylmalonyl-CoA pathway to improve ascomycin production in Streptomyces hygroscopicus var. ascomyceticus. Microb Cell Fact (2017) 0.75
Close to the Edge: Growth Restrained by the NAD(P)H/ATP Formation Flux Ratio. Front Microbiol (2017) 0.75
From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res (2006) 44.35
ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res (2003) 17.39
Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A (2007) 11.46
A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol (2007) 11.03
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res (2009) 7.33
Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res (2004) 6.21
TCDB: the Transporter Classification Database for membrane transport protein analyses and information. Nucleic Acids Res (2006) 5.31
Network-based prediction of human tissue-specific metabolism. Nat Biotechnol (2008) 4.39
The biology of Zymomonas. Bacteriol Rev (1977) 4.23
Genome-scale metabolic model of Helicobacter pylori 26695. J Bacteriol (2002) 4.00
TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res (2006) 3.10
Genetic engineering of ethanol production in Escherichia coli. Appl Environ Microbiol (1987) 3.06
Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Syst Biol (2009) 2.80
Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. Metab Eng (2005) 2.60
The comprehensive microbial resource. Nucleic Acids Res (2009) 2.46
Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A (2007) 2.43
Metabolic Engineering of a Pentose Metabolism Pathway in Ethanologenic Zymomonas mobilis. Science (1995) 2.40
Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol (2007) 2.18
Systems biotechnology for strain improvement. Trends Biotechnol (2005) 1.98
The genome sequence of the ethanologenic bacterium Zymomonas mobilis ZM4. Nat Biotechnol (2004) 1.98
BRENDA: a resource for enzyme data and metabolic information. Trends Biochem Sci (2002) 1.97
In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production. Metab Eng (2005) 1.96
Toward metabolic phenomics: analysis of genomic data using flux balances. Biotechnol Prog (1999) 1.93
Efficient ethanol production from glucose, lactose, and xylose by recombinant Escherichia coli. Appl Environ Microbiol (1989) 1.91
AraGEM, a genome-scale reconstruction of the primary metabolic network in Arabidopsis. Plant Physiol (2009) 1.81
Improvement of microbial strains and fermentation processes. Appl Microbiol Biotechnol (2000) 1.77
The genome sequence of the capnophilic rumen bacterium Mannheimia succiniciproducens. Nat Biotechnol (2004) 1.64
Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers. Biotechnol Bioeng (2010) 1.36
Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering. Appl Environ Microbiol (1996) 1.31
Improved genome annotation for Zymomonas mobilis. Nat Biotechnol (2009) 1.30
Application of systems biology for bioprocess development. Trends Biotechnol (2008) 1.30
Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci U S A (2007) 1.26
Lipid composition of Zymomonas mobilis: effects of ethanol and glucose. J Bacteriol (1983) 1.24
Genome-based metabolic engineering of Mannheimia succiniciproducens for succinic acid production. Appl Environ Microbiol (2006) 1.21
Analysis of Aspergillus nidulans metabolism at the genome-scale. BMC Genomics (2008) 1.20
Content and composition of hopanoids in Zymomonas mobilis under various growth conditions. J Bacteriol (1991) 1.16
Cloning of conserved genes from Zymomonas mobilis and Bradyrhizobium japonicum that function in the biosynthesis of hopanoid lipids. Biochim Biophys Acta (1998) 1.14
BioSilico: an integrated metabolic database system. Bioinformatics (2004) 1.12
Cellular and metabolic engineering. An overview. Appl Biochem Biotechnol (1993) 1.11
Towards systems metabolic engineering of microorganisms for amino acid production. Curr Opin Biotechnol (2008) 1.07
Reconstruction of the central carbon metabolism of Aspergillus niger. Eur J Biochem (2003) 1.05
Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst (2009) 1.02
The effect of ethanol and oxygen on the growth of Zymomonas mobilis and the levels of hopanoids and other membrane lipids. Curr Microbiol (1997) 1.01
Metabolic state of Zymomonas mobilis in glucose-, fructose-, and xylose-fed continuous cultures as analysed by 13C- and 31P-NMR spectroscopy. Arch Microbiol (1999) 0.97
Genome-scale modeling and in silico analysis of mouse cell metabolic network. Mol Biosyst (2009) 0.95
Zymomonas mobilis: a bacterium for ethanol production. Biotechnol Adv (1986) 0.95
Flux-sum analysis: a metabolite-centric approach for understanding the metabolic network. BMC Syst Biol (2009) 0.94
Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses. Proc Natl Acad Sci U S A (2010) 0.94
MetaFluxNet, a program package for metabolic pathway construction and analysis, and its use in large-scale metabolic flux analysis of Escherichia coli. Genome Inform (2003) 0.86
Metabolic flux control at the pyruvate node in an anaerobic Escherichia coli strain with an active pyruvate dehydrogenase. Appl Environ Microbiol (2010) 0.85
Quantifying the metabolic capabilities of engineered Zymomonas mobilis using linear programming analysis. Microb Cell Fact (2007) 0.82
Kinetic and nuclear magnetic resonance studies of xylose metabolism by recombinant Zymomonas mobilis ZM4(pZB5). Appl Environ Microbiol (2000) 0.81
Analysis of intact hopanoids and other lipids from the bacterium Zymomonas mobilis by high-performance liquid chromatography. Anal Biochem (1995) 0.80
A novel aerobic respiratory chain-linked NADH oxidase system in Zymomonas mobilis. J Bacteriol (1995) 0.79
MFAML: a standard data structure for representing and exchanging metabolic flux models. Bioinformatics (2005) 0.79
Composite hopanoid biosynthesis in Zymomonas mobilis: N-acetyl-D-glucosamine as precursor for the cyclopentane ring linked to bacteriohopanetetrol. Chem Commun (Camb) (2003) 0.77
Simultaneous ethanol and bacterial ice nuclei production from sugar beet molasses by a Zymomonas mobilis CP4 mutant expressing the inaZ gene of Pseudomonas syringae in continuous culture. J Appl Microbiol (2000) 0.76
Synthesis of the aminocyclopentitol moieties of the hopanoids of Zymomonas mobilis and 'Anacystis montana'. Chem Commun (Camb) (2003) 0.76
Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol (2011) 3.55
Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A (2007) 2.43
Thyroid nodules with initially nondiagnostic cytologic results: the role of core-needle biopsy. Radiology (2013) 2.34
Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol (2007) 2.18
Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol (2012) 2.17
Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation. Appl Environ Microbiol (2005) 2.13
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol (2010) 2.04
Systems biotechnology for strain improvement. Trends Biotechnol (2005) 1.98
Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) (2004) 1.96
Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat Biotechnol (2013) 1.76
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74
The genome sequence of the capnophilic rumen bacterium Mannheimia succiniciproducens. Nat Biotechnol (2004) 1.64
The genome sequence of E. coli W (ATCC 9637): comparative genome analysis and an improved genome-scale reconstruction of E. coli. BMC Genomics (2011) 1.63
Microbial production of short-chain alkanes. Nature (2013) 1.61
Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol Adv (2009) 1.60
Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber. Proc Natl Acad Sci U S A (2010) 1.51
Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol (2011) 1.50
Detection of the most common corneal dystrophies caused by BIGH3 gene point mutations using a multispot gold-capped nanoparticle array chip. Anal Chem (2010) 1.41
Recent advances in reconstruction and applications of genome-scale metabolic models. Curr Opin Biotechnol (2011) 1.41
MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis. Bioinformatics (2003) 1.40
Comparative multi-omics systems analysis of Escherichia coli strains B and K-12. Genome Biol (2012) 1.37
Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers. Biotechnol Bioeng (2010) 1.36
Identification and characterization of a new enoyl coenzyme A hydratase involved in biosynthesis of medium-chain-length polyhydroxyalkanoates in recombinant Escherichia coli. J Bacteriol (2003) 1.35
Genome-scale reconstruction and in silico analysis of the Clostridium acetobutylicum ATCC 824 metabolic network. Appl Microbiol Biotechnol (2008) 1.34
Systems biology as a foundation for genome-scale synthetic biology. Curr Opin Biotechnol (2006) 1.31
Application of systems biology for bioprocess development. Trends Biotechnol (2008) 1.30
Complete genome sequence of the metabolically versatile plant growth-promoting endophyte Variovorax paradoxus S110. J Bacteriol (2010) 1.29
Genome-scale analysis of Mannheimia succiniciproducens metabolism. Biotechnol Bioeng (2007) 1.28
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2009) 1.27
Organizational and mutational analysis of a complete FR-008/candicidin gene cluster encoding a structurally related polyene complex. Chem Biol (2003) 1.27
Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci U S A (2007) 1.26
Bio-based production of C2-C6 platform chemicals. Biotechnol Bioeng (2012) 1.25
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) (2004) 1.24
Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. Biotechnol Bioeng (2003) 1.24
Enhanced butanol production obtained by reinforcing the direct butanol-forming route in Clostridium acetobutylicum. MBio (2012) 1.24
The Escherichia coli proteome: past, present, and future prospects. Microbiol Mol Biol Rev (2006) 1.23
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2008) 1.23
Metabolic engineering of Escherichia coli for the production of cadaverine: a five carbon diamine. Biotechnol Bioeng (2011) 1.21
Genome-based metabolic engineering of Mannheimia succiniciproducens for succinic acid production. Appl Environ Microbiol (2006) 1.21
In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol (2010) 1.18
Systems metabolic engineering for chemicals and materials. Trends Biotechnol (2011) 1.17
Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience. Endocr J (2013) 1.16
Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli. Biotechnol Bioeng (2008) 1.16
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol (2013) 1.16
Patterned multiplex pathogen DNA detection by Au particle-on-wire SERS sensor. Nano Lett (2010) 1.15
Biosynthesis of polylactic acid and its copolymers using evolved propionate CoA transferase and PHA synthase. Biotechnol Bioeng (2010) 1.14
Novel gene members in the Pho regulon of Escherichia coli. FEMS Microbiol Lett (2006) 1.13
BioSilico: an integrated metabolic database system. Bioinformatics (2004) 1.12
18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab (2007) 1.11
Continuous butanol production with reduced byproducts formation from glycerol by a hyper producing mutant of Clostridium pasteurianum. Appl Microbiol Biotechnol (2011) 1.08
Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng (2009) 1.07
Applications of DNA microarray in disease diagnostics. J Microbiol Biotechnol (2009) 1.07
Towards systems metabolic engineering of microorganisms for amino acid production. Curr Opin Biotechnol (2008) 1.07
Genome-scale metabolic model of methylotrophic yeast Pichia pastoris and its use for in silico analysis of heterologous protein production. Biotechnol J (2010) 1.07
Fermentative production of branched chain amino acids: a focus on metabolic engineering. Appl Microbiol Biotechnol (2010) 1.06
Microbial production of building block chemicals and polymers. Curr Opin Biotechnol (2011) 1.06
Prediction of novel synthetic pathways for the production of desired chemicals. BMC Syst Biol (2010) 1.05
Metabolic engineering of Clostridium acetobutylicum ATCC 824 for isopropanol-butanol-ethanol fermentation. Appl Environ Microbiol (2011) 1.05
Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf) (2008) 1.05
Metabolic engineering of Escherichia coli for the production of putrescine: a four carbon diamine. Biotechnol Bioeng (2009) 1.05
DNA microarray-based identification of bacterial and fungal pathogens in bloodstream infections. Mol Cell Probes (2009) 1.04
Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today (2008) 1.04
Enhanced production of insulin-like growth factor I fusion protein in Escherichia coli by coexpression of the down-regulated genes identified by transcriptome profiling. Appl Environ Microbiol (2003) 1.03
Comparison of the extracellular proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. Proteomics (2008) 1.02
Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst (2009) 1.02
Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid (2014) 1.01
Technical and oncologic safety of robotic thyroid surgery. Ann Surg Oncol (2013) 1.01
Metabolic engineering of Escherichia coli for the production of 1-propanol. Metab Eng (2012) 1.00
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid (2012) 1.00
Butanol production from renewable biomass: rediscovery of metabolic pathways and metabolic engineering. Biotechnol J (2011) 1.00
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol (2013) 0.99
Construction and optimization of synthetic pathways in metabolic engineering. Curr Opin Microbiol (2010) 0.99
Metabolic engineering of Escherichia coli for the production of 5-aminovalerate and glutarate as C5 platform chemicals. Metab Eng (2012) 0.99
Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J (2009) 0.98
Engineering of microorganisms for the production of biofuels and perspectives based on systems metabolic engineering approaches. Biotechnol Adv (2011) 0.98
NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma. Thyroid (2014) 0.98
Excretion of human beta-endorphin into culture medium by using outer membrane protein F as a fusion partner in recombinant Escherichia coli. Appl Environ Microbiol (2002) 0.97
Development of a markerless gene knock-out system for Mannheimia succiniciproducens using a temperature-sensitive plasmid. FEMS Microbiol Lett (2007) 0.97
Metabolic engineering of Clostridium acetobutylicum M5 for highly selective butanol production. Biotechnol J (2009) 0.96